Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Kenneth Amory currently holds 5,766 shares of Clarus Therapeutics Holdings, Inc. (CRXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Kenneth Amory has been a net neutral trader of CRXT stock. They have purchased $0 and sold $0 worth of shares.
John Kenneth Amory's most recent insider trade was on Jun 7, 2022, when they sold 1,922 shares at $0.00 per share.
John Kenneth Amory serves as Executive at Clarus Therapeutics Holdings, Inc. (CRXT). They have executed 2 insider transactions totaling $0 over their tenure at the company.
John Kenneth Amory holds the position of Executive at Clarus Therapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
John Kenneth Amory has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by John Kenneth Amory was on Jun 7, 2022, when they purchased $0 worth of CRXT shares. This transaction involved 1,922 shares at N/A per share.
John Kenneth Amory currently owns 5,766 shares of Clarus Therapeutics Holdings, Inc. (CRXT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Kenneth Amory's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Kenneth Amory has 2 Form 4 filings on record as an insider at Clarus Therapeutics Holdings, Inc..
Set alerts for John Kenneth Amory and 40,000+ other insiders.